BMS, bluebird bio bag Abecma FDA approval for multiple myeloma in adults
Abecma FDA approval : Bristol Myers Squibb (BMS) and bluebird bio have secured approval from the US Food and Drug Administration (FDA) for Abecma (idecabtagene vicleucel; ide-cel) for the treatment of relapsed or refractory multiple myeloma. The approval is for Abecma’s use in the treatment of relapsed or refractory multiple myeloma in adult patients following […]